BC-11-38,PDE-11抑制剂
|
B275042-250mg
|
Moligand™, ≥97% |
686770-80-9 |
250mg
|
¥ 8999.9
|
现货 |
阿拉丁 |
BC-11-38,PDE-11抑制剂
|
B275042-100mg
|
Moligand™, ≥97% |
686770-80-9 |
100mg
|
¥ 4999.9
|
现货 |
阿拉丁 |
抗坏血酸
|
A640026-25kg
|
Moligand™, ≥97% |
50-81-7 |
25kg
|
¥ 1894.9
|
现货 |
阿拉丁 |
抗坏血酸
|
A640026-2.5kg
|
Moligand™, ≥97% |
50-81-7 |
2.5kg
|
¥ 389.9
|
现货 |
阿拉丁 |
抗坏血酸
|
A640026-10kg
|
Moligand™, ≥97% |
50-81-7 |
10kg
|
¥ 992.9
|
现货 |
阿拉丁 |
2-氨基-4-溴苯甲酸
|
A639780-250mg
|
≥90% |
20776-50-5 |
250mg
|
¥ 29.9
|
现货 |
阿拉丁 |
2-氨基-4-溴苯甲酸
|
A639780-1g
|
≥90% |
20776-50-5 |
1g
|
¥ 29.9
|
现货 |
阿拉丁 |
N-十八烷基丙烯酰胺
|
A467496-1g
|
≥95% |
1506-54-3 |
1g
|
¥ 167.9
|
期货,请咨询 |
阿拉丁 |
Ala-D-γ-Glu-Lys-D-Ala-D-Ala TFA
|
A464331-50mg
|
≥97%(HPLC) |
2614-55-3 |
50mg
|
¥ 8999.9
|
现货 |
阿拉丁 |
Ala-D-γ-Glu-Lys-D-Ala-D-Ala TFA
|
A464331-25mg
|
≥97%(HPLC) |
2614-55-3 |
25mg
|
¥ 5999.9
|
现货 |
阿拉丁 |
Ala-D-γ-Glu-Lys-D-Ala-D-Ala TFA
|
A464331-1mg
|
≥97%(HPLC) |
2614-55-3 |
1mg
|
¥ 599.9
|
现货 |
阿拉丁 |
Ala-D-γ-Glu-Lys-D-Ala-D-Ala TFA
|
A464331-10mg
|
≥97%(HPLC) |
2614-55-3 |
10mg
|
¥ 3399.9
|
现货 |
阿拉丁 |
Apcin-A
|
A412850-5mg
|
≥98% |
1683617-62-0 |
5mg
|
¥ 2404.9
|
现货 |
阿拉丁 |
Apcin-A
|
A412850-10mg
|
≥98% |
1683617-62-0 |
10mg
|
¥ 3847.9
|
现货 |
阿拉丁 |
氨基-PEG9-胺
|
A412715-50mg
|
≥97% |
474082-35-4 |
50mg
|
¥ 279.9
|
现货 |
阿拉丁 |
氨基-PEG9-胺
|
A412715-250mg
|
≥97% |
474082-35-4 |
250mg
|
¥ 542.9
|
现货 |
阿拉丁 |
叠氮-PEG9-酸
|
A412482-250mg
|
≥95% |
1670249-37-2 |
250mg
|
¥ 659.9
|
现货 |
阿拉丁 |
叠氮-PEG9-酸
|
A412482-1g
|
≥95% |
1670249-37-2 |
1g
|
¥ 1599.9
|
现货 |
阿拉丁 |
AZD7594
|
A412393-50mg
|
Moligand™, ≥98% |
1196509-60-0 |
50mg
|
¥ 6299.9
|
现货 |
阿拉丁 |
AZD7594
|
A412393-1mg
|
Moligand™, ≥98% |
1196509-60-0 |
1mg
|
¥ 369.9
|
现货 |
阿拉丁 |
AZD7594
|
A412393-10mg
|
Moligand™, ≥98% |
1196509-60-0 |
10mg
|
¥ 1699.9
|
现货 |
阿拉丁 |
AZD7594
|
A412393-100mg
|
Moligand™, ≥98% |
1196509-60-0 |
100mg
|
¥ 9999.9
|
现货 |
阿拉丁 |
AZ9482
|
A412343-50mg
|
≥98% |
1825345-33-2 |
50mg
|
¥ 1499.9
|
现货 |
阿拉丁 |
AZ9482
|
A412343-1mg
|
≥98% |
1825345-33-2 |
1mg
|
¥ 149.9
|
现货 |
阿拉丁 |